Special Issue "Alpha-Synuclein in Neurological Disorders: From Physiology to Pathology"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 183

Special Issue Editors
Interests: neurodegenerative diseases; neuronal cell death; protein aggregation; autophagy-lysosome pathway; animal models
Special Issues, Collections and Topics in MDPI journals

Interests: adult cell regeneration (neurogenesis and gliogenesis); neuron/astrocytes interaction; astrocyte biology; iPSc-derived neural cells, Parkinson disease; brain ischemia
Special Issues, Collections and Topics in MDPI journals
Interests: extracellular matrix; microglia; neurodegeneration; Parkinson’s disease; brain ischemia; live imaging; image analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The physiological role of the protein α-synuclein is widely debated. It is expressed constitutively in neurons and found in glia under certain pathological conditions. More recently, the function of α-synuclein in the CNS has been associated with the regulation of exocytotic neurotransmitter release at the synapse. The fibrillary aggregation of α-synuclein and its spread throughout neuroanatomically connected regions are hallmarks of a series of neuropathologies termed synucleinopathies, including Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure, and multiple system atrophy. Since the discovery of α-synuclein in Lewy bodies in 1997, a wealth of information about this protein has become available. However, several questions remain unanswered: is α-synuclein aggregation a cause or effect of the pathological process? What determines the transition from the physiological to pathological state of α-synuclein? Is neuronal α-synuclein different from the α-synuclein found in glial cells? Is it worth using α-synuclein in animal models? In this Special Issue, we aim to shed light upon the complex scenario of α-synuclein’s transition from physiology to pathology in synucleinopathies, with a wide view from the clinic to basic experimental knowledge.
Dr. Benjamin Dehay
Dr. Fabio Cavaliere
Dr. Federico N. Soria
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroinflammation
- neurodegeneration
- gliosis
- synaptic function
- exocytosis
- endocytosis